Canada vs Republic of Korea: Deaths from Parkinson's disease
Canada
3,587 deaths
in 2021
Republic of Korea
4,630 deaths
in 2021
Canada rank
17th
Republic of Korea rank
15th
Deaths from Parkinson's disease over time
- Canada
- Republic of Korea
How they compare
Republic of Korea currently reports 4,630 deaths against 3,587 deaths in Canada, a difference of 1,043 deaths.
That makes Republic of Korea's figure about 1.3 times Canada's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Canada ahead.
Canada ranks 17th and Republic of Korea ranks 15th of 194 countries.
Across the 3 decades both report, Canada averaged higher in 1 and Republic of Korea in 2.
Head to head by decade
| Decade | Canada | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,762 deaths | 1,305 deaths | 456.21 deaths | Canada |
| 2010s | 2,623 deaths | 3,578 deaths | 955.14 deaths | Republic of Korea |
| 2020s | 3,546 deaths | 4,423 deaths | 876.67 deaths | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Canada or Republic of Korea?
- Republic of Korea, at 4,630 deaths against 3,587 deaths in Canada as of 2021.
- What is the difference in deaths from parkinson's disease between Canada and Republic of Korea?
- 1,043 deaths, with Republic of Korea ahead.
- How many years of comparable data are there for Canada and Republic of Korea?
- 22 years are reported by both, from 2000 to 2021.
- How do Canada and Republic of Korea rank globally for deaths from parkinson's disease?
- Canada ranks 17th and Republic of Korea ranks 15th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.